Inside out: Bone marrow adipose tissue as a source of circulating adiponectin

Adipocyte

Volumn 5, Issue 3, 2016, Pages 251-269

  Scheller, Erica L ^a   Burr, Aaron A ^b   MacDougald, Ormond A ^b   Cawthorn, William P ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

adiponectin; anorexia nervosa; bone marrow adipose tissue; caloric restriction; lipodystrophy; obesity; white adipose tissue

Indexed keywords

ADIPONECTIN; LEPTIN;

ADIPOSE TISSUE; ANOREXIA NERVOSA; BONE MARROW; BROWN ADIPOSE TISSUE; CALORIC RESTRICTION; CARDIOVASCULAR RISK; CELL ISOLATION; HYPOADIPONECTINEMIA; LIPODYSTROPHY; OBESITY; PROTEIN EXPRESSION; REVIEW; WHITE ADIPOSE TISSUE;

EID: 84992074784     PISSN: 21623945     EISSN: 2162397X     Source Type: Journal    
DOI: 10.1080/21623945.2016.1149269     Document Type: Review

References (138)

1. T.Romacho, M.Elsen, D.Rohrborn, J.Eckel. Adipose tissue and its role in organ crosstalk. Acta physiologica 2014; 210:733-53; PMID:24495317; http://dx.doi.org/10.1111/apha.12246
2. P.E.E.Scherer. Adiponectin:basic and clinical aspects [Special Issue]. Best Pract Res Clin Endocrinol Metab 2014; 28:1-130; PMID:24417940; http://dx.doi.org/10.1016/j.beem.2013.11.004
3. R.Ye, P.E.Scherer. Adiponectin, driver or passenger on the road to insulin sensitivity? Mol Metab 2013; 2:133-41; PMID:24049728; http://dx.doi.org/10.1016/j.molmet.2013.04.001
4. W.P.Cawthorn, E.L.Scheller, B.S.Learman, S.D.Parlee, B.R.Simon, H.Mori, X.Ning, A.J.Bree, B.Schell, D.T.Broome, et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metab 2014; 20:368-75; PMID:24998914; http://dx.doi.org/10.1016/j.cmet.2014.06.003
5. Y.Arita, S.Kihara, N.Ouchi, M.Takahashi, K.Maeda, J.Miyagawa, K.Hotta, I.Shimomura, T.Nakamura, K.Miyaoka, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257:79-83; PMID:10092513; http://dx.doi.org/10.1006/bbrc.1999.0255
6. N.Halberg, T.D.Schraw, Z.V.Wang, J.Y.Kim, J.Yi, M.P.Hamilton, K.Luby-Phelps, P.E.Scherer. Systemic fate of the adipocyte-derived factor adiponectin. Diabetes 2009; 58:1961-70; PMID:19581422; http://dx.doi.org/10.2337/db08-1750
7. M.L.Delporte, S.M.Brichard, M.P.Hermans, C.Beguin, M.Lambert. Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) 2003; 58:22-9; PMID:12519408; http://dx.doi.org/10.1046/j.1365-2265.2003.01702.x
8. T.P.Combs, A.H.Berg, M.W.Rajala, S.Klebanov, P.Iyengar, J.C.Jimenez-Chillaron, M.E.Patti, S.L.Klein, R.S.Weinstein, P.E.Scherer. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003; 52:268-76; PMID:12540596; http://dx.doi.org/10.2337/diabetes.52.2.268
9. R.Dolezalova, Z.Lacinova, M.Dolinkova, P.Kleiblova, D.Haluzikova, D.Housa, H.Papezova, M.Haluzik. Changes of endocrine function of adipose tissue in anorexia nervosa:comparison of circulating levels versus subcutaneous mRNA expression. Clin Endocrinol (Oxf) 2007; 67:674-8; PMID:17953628; http://dx.doi.org/10.1111/j.1365-2265.2007.02944.x
10. L.Qiao, B.Lee, B.Kinney, H.S.Yoo, J.Shao. Energy intake and adiponectin gene expression. Am J Physiol Endocrinol Metab 2011; 300:E809-16; PMID:21325106; http://dx.doi.org/10.1152/ajpendo.00004.2011
11. M.Zhu, G.D.Lee, L.Ding, J.Hu, G.Qiu, R.de Cabo, M.Bernier, D.K.Ingram, S.Zou. Adipogenic signaling in rat white adipose tissue:modulation by aging and calorie restriction. Exp Gerontol 2007; 42:733-44; PMID:17624709; http://dx.doi.org/10.1016/j.exger.2007.05.011
12. S.Rohrbach, A.C.Aurich, L.Li, B.Niemann. Age-associated loss in adiponectin-activation by caloric restriction:lack of compensation by enhanced inducibility of adiponectin paralogs CTRP2 and CTRP7. Mol Cell Endocrinol 2007; 277:26-34; PMID:17716811; http://dx.doi.org/10.1016/j.mce.2007.07.005
13. S.Park, T.Komatsu, H.Hayashi, L.S.Trindade, H.Yamaza, T.Chiba, I.Shimokawa. Divergent regulation of adipose tissue metabolism by calorie restriction and inhibition of growth hormone signaling. Exp Gerontol 2009; 44:646-52; PMID:19646410; http://dx.doi.org/10.1016/j.exger.2009.07.002
14. Q.Ding, C.Ash, T.Mracek, B.Merry, C.Bing. Caloric restriction increases adiponectin expression by adipose tissue and prevents the inhibitory effect of insulin on circulating adiponectin in rats. J Nutr Biochem 2012; 23:867-74; PMID:21852089; http://dx.doi.org/10.1016/j.jnutbio.2011.04.011
15. Y.Dai, J.Pang, H.Gong, W.Fan, T.M.Zhang. Roles and tissue source of adiponectin involved in lifestyle modifications. J Gerontol A Biol Sci Med Sci 2013; 68:117-28; PMID:22562959; http://dx.doi.org/10.1093/gerona/gls131
16. D.S.Wiesenborn, V.Menon, X.Zhi, A.Do, A.Gesing, Z.Wang, A.Bartke, D.A.Altomare, M.M.Masternak. The effect of calorie restriction on insulin signaling in skeletal muscle and adipose tissue of Ames dwarf mice. Aging (Albany NY) 2014; 6:900-12; PMID:25411241
17. J.H.Chen, C.Ouyang, Q.Ding, J.Song, W.Cao, L.Mao. A Moderate Low-Carbohydrate Low-Calorie Diet Improves Lipid Profile, Insulin Sensitivity and Adiponectin Expression in Rats. Nutrients 2015; 7:4724-38; PMID:26110252; http://dx.doi.org/10.3390/nu7064724
18. Y.Higami, T.D.Pugh, G.P.Page, D.B.Allison, T.A.Prolla, R.Weindruch. Adipose tissue energy metabolism:altered gene expression profile of mice subjected to long-term caloric restriction. FASEB journal:official publication of the Federation of American Societies for Experimental Biology 2004; 18:415-7; PMID:14688200
19. Z.Wang, K.A.Al-Regaiey, M.M.Masternak, A.Bartke. Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. The journals of gerontology Series A, Biological sciences and medical sciences 2006; 61:323-31; PMID:16611697; http://dx.doi.org/10.1093/gerona/61.4.323
20. M.Tahmoorespur, S.Ghazanfari, K.Nobari. Evaluation of adiponectin gene expression in the abdominal adipose tissue of broiler chickens:feed restriction, dietary energy, and protein influences adiponectin messenger ribonucleic acid expression. Poult Sci 2010; 89:2092-100; PMID:20852099; http://dx.doi.org/10.3382/ps.2010-00772
21. S.Zgheib, M.Mequinion, S.Lucas, D.Leterme, O.Ghali, V.Tolle, P.Zizzari, N.Bellefontaine, I.Legroux-Gerot, P.Hardouin, et al. Long-term physiological alterations and recovery in a mouse model of separation associated with time-restricted feeding:a tool to study anorexia nervosa related consequences. PLoS One 2014; 9:e103775; PMID:25090643; http://dx.doi.org/10.1371/journal.pone.0103775
22. X.Wang, T.You, K.Murphy, M.F.Lyles, B.J.Nicklas. Addition of Exercise Increases Plasma Adiponectin and Release from Adipose Tissue. Med Sci Sports Exerc 2015
23. N.Rasouli, A.Yao-Borengasser, L.M.Miles, S.C.Elbein, P.A.Kern. Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression. Am J Physiol Endocrinol Metab 2006; 290:E42-E6; PMID:16118250; http://dx.doi.org/10.1152/ajpendo.00240.2005
24. E.D.Rosen, B.M.Spiegelman. What we talk about when we talk about fat. Cell 2014; 156:20-44; PMID:24439368; http://dx.doi.org/10.1016/j.cell.2013.12.012
25. P.K.Fazeli, M.C.Horowitz, O.A.Macdougald, E.L.Scheller, M.S.Rodeheffer, C.J.Rosen, A.Klibanski. Marrow fat and bone–new perspectives. J Clin Endocrinol Metab 2013; 98:935-45; PMID:23393168; http://dx.doi.org/10.1210/jc.2012-3634
26. M.J.Devlin. Why does starvation make bones fat? Am J Hum Biol 2011; 23:577-85; PMID:21793093; http://dx.doi.org/10.1002/ajhb.21202
27. H.S.Berner, S.P.Lyngstadaas, A.Spahr, M.Monjo, L.Thommesen, C.A.Drevon, U.Syversen, J.E.Reseland. Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004; 35:842-9; PMID:15454091; http://dx.doi.org/10.1016/j.bone.2004.06.008
28. Y.Shinoda, M.Yamaguchi, N.Ogata, T.Akune, N.Kubota, T.Yamauchi, Y.Terauchi, T.Kadowaki, Y.Takeuchi, S.Fukumoto, et al. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 2006; 99:196-208; PMID:16598753; http://dx.doi.org/10.1002/jcb.20890
29. L.DiMascio, C.Voermans, M.Uqoezwa, A.Duncan, D.Lu, J.Wu, U.Sankar, T.Reya. Identification of adiponectin as a novel hemopoietic stem cell growth factor. J Immunol 2007; 178:3511-20; PMID:17339446; http://dx.doi.org/10.4049/jimmunol.178.6.3511
30. L.Thorrez, K.Van Deun, L.C.Tranchevent, L.Van Lommel, K.Engelen, K.Marchal, Y.Moreau, I.Van Mechelen, F.Schuit. Using ribosomal protein genes as reference:a tale of caution. PLoS One 2008; 3:e1854; PMID:18365009; http://dx.doi.org/10.1371/journal.pone.0001854
31. J.E.Lattin, K.Schroder, A.I.Su, J.R.Walker, J.Zhang, T.Wiltshire, K.Saijo, C.K.Glass, D.A.Hume, S.Kellie, et al. Expression analysis of G Protein-Coupled Receptors in mouse macrophages. Immunome Res 2008; 4:5; PMID:18442421; http://dx.doi.org/10.1186/1745-7580-4-5
32. K.Uchihashi, S.Aoki, M.Shigematsu, N.Kamochi, E.Sonoda, H.Soejima, K.Fukudome, H.Sugihara, T.Hotokebuchi, S.Toda. Organotypic culture of human bone marrow adipose tissue. Pathol Int 2010; 60:259-67; PMID:20403027; http://dx.doi.org/10.1111/j.1440-1827.2010.02511.x
33. F.Ugarte, M.Ryser, S.Thieme, F.A.Fierro, K.Navratiel, M.Bornhauser, S.Brenner. Notch signaling enhances osteogenic differentiation while inhibiting adipogenesis in primary human bone marrow stromal cells. Exp Hematol 2009; 37:867-75 e1; PMID:19540436; http://dx.doi.org/10.1016/j.exphem.2009.03.007
34. L.Xiao, T.Sobue, A.Esliger, M.S.Kronenberg, J.D.Coffin, T.Doetschman, M.M.Hurley. Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells. Bone 2010; 47:360-70; PMID:20510392; http://dx.doi.org/10.1016/j.bone.2010.05.021
35. T.Yokota, C.S.Meka, K.L.Medina, H.Igarashi, P.C.Comp, M.Takahashi, M.Nishida, K.Oritani, J.Miyagawa, T.Funahashi, et al. Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest 2002; 109:1303-10; PMID:12021245; http://dx.doi.org/10.1172/JCI0214506
36. L.F.Liu, W.J.Shen, M.Ueno, S.Patel, F.B.Kraemer. Characterization of age-related gene expression profiling in bone marrow and epididymal adipocytes. BMC Genomics 2011; 12:212; PMID:21545734; http://dx.doi.org/10.1186/1471-2164-12-212
37. M.Iwaki, M.Matsuda, N.Maeda, T.Funahashi, Y.Matsuzawa, M.Makishima, I.Shimomura. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003; 52:1655-63; PMID:12829629; http://dx.doi.org/10.2337/diabetes.52.7.1655
38. N.Maeda, M.Takahashi, T.Funahashi, S.Kihara, H.Nishizawa, K.Kishida, H.Nagaretani, M.Matsuda, R.Komuro, N.Ouchi, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50:2094-9; PMID:11522676; http://dx.doi.org/10.2337/diabetes.50.9.2094
39. B.Gustafson, M.M.Jack, S.W.Cushman, U.Smith. Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes. Biochem Biophys Res Commun 2003; 308:933-9; PMID:12927809; http://dx.doi.org/10.1016/S0006-291X(03)01518-3
40. B.-H.Park, L.Qiang, S.R.Farmer. Phosphorylation of C/EBP{beta} at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of Mouse fibroblasts into adipocytes. Mol Cell Biol 2004; 24:8671-80; http://dx.doi.org/10.1128/MCB.24.19.8671-8680.2004
41. L.Qiao, P.S.Maclean, J.Schaack, D.J.Orlicky, C.Darimont, M.Pagliassotti, J.E.Friedman, J.Shao. C/EBPalpha regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 2005; 54:1744-54; PMID:15919796; http://dx.doi.org/10.2337/diabetes.54.6.1744
42. Q.A.Wang, C.Tao, L.Jiang, M.Shao, R.Ye, Y.Zhu, R.Gordillo, A.Ali, Y.Lian, W.L.Holland, et al. Distinct regulatory mechanisms governing embryonic versus adult adipocyte maturation. Nat Cell Biol 2015; 17:1099-111; PMID:26280538; http://dx.doi.org/10.1038/ncb3217
43. M.Ferron, E.Hinoi, G.Karsenty, P.Ducy. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A 2008; 105:5266-70; PMID:18362359; http://dx.doi.org/10.1073/pnas.0711119105
44. M.Degawa-Yamauchi, K.A.Moss, J.E.Bovenkerk, S.S.Shankar, C.L.Morrison, C.J.Lelliott, A.Vidal-Puig, R.Jones, R.V.Considine. Regulation of adiponectin expression in human adipocytes:effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res 2005; 13:662-9; PMID:15897474; http://dx.doi.org/10.1038/oby.2005.74
45. P.J.Simons, P.S.van den Pangaart, C.P.van Roomen, J.M.Aerts, L.Boon. Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis:evidence that tumor necrosis factor-alpha- and interleukin-1beta-treated human preadipocytes are potent leptin producers. Cytokine 2005; 32:94-103; PMID:16213747; http://dx.doi.org/10.1016/j.cyto.2005.08.003
46. A.Poloni, G.Maurizi, F.Serrani, S.Mancini, M.C.Zingaretti, A.Frontini, S.Cinti, A.Olivieri, P.Leoni. Molecular and functional characterization of human bone marrow adipocytes. Exp Hematol 2013; 41:558-66 e2; PMID:23435314; http://dx.doi.org/10.1016/j.exphem.2013.02.005
47. D.Kajimura, H.W.Lee, K.J.Riley, E.Arteaga-Solis, M.Ferron, B.Zhou, C.J.Clarke, Y.A.Hannun, R.A.Depinho, E.X.Guo, et al. Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metab 2013; PMID:23684624
48. D.M.Hayman, T.J.Blumberg, C.C.Scott, K.A.Athanasiou. The effects of isolation on chondrocyte gene expression. Tissue Eng 2006; 12:2573-81; PMID:16995790; http://dx.doi.org/10.1089/ten.2006.12.2573
49. E.L.Scheller, C.R.Doucette, B.S.Learman, W.P.Cawthorn, S.Khandaker, B.Schell, B.Wu, S.Y.Ding, M.A.Bredella, P.K.Fazeli, et al. Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues. Nat Commun 2015; 6:7808; PMID:26245716; http://dx.doi.org/10.1038/ncomms8808
50. M.Ryden, A.Dicker, C.Gotherstrom, G.Astrom, C.Tammik, P.Arner, K.Le Blanc. Functional characterization of human mesenchymal stem cell-derived adipocytes. Biochem Biophys Res Commun 2003; 311:391-7; PMID:14592427; http://dx.doi.org/10.1016/j.bbrc.2003.10.010
51. A.Hozumi, M.Osaki, K.Sakamoto, H.Goto, T.Fukushima, H.Baba, H.Shindo. Dexamethasone-induced plasminogen activator inhibitor-1 expression in human primary bone marrow adipocytes. Biomed Res 2010; 31:281-6; PMID:21079357; http://dx.doi.org/10.2220/biomedres.31.281
52. M.Liu, L.Zhou, A.Xu, K.S.Lam, M.D.Wetzel, R.Xiang, J.Zhang, X.Xin, L.Q.Dong, F.Liu. A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. Proc Natl Acad Sci U S A 2008; 105:18302-7; PMID:19011089; http://dx.doi.org/10.1073/pnas.0806341105
53. Z.V.Wang, T.D.Schraw, J.Y.Kim, T.Khan, M.W.Rajala, A.Follenzi, P.E.Scherer. Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol Cell Biol 2007; 27:3716-31; PMID:17353260; http://dx.doi.org/10.1128/MCB.00931-06
54. L.Qiang, H.Wang, S.R.Farmer. Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha. Mol Cell Biol 2007; 27:4698-707; PMID:17452443; http://dx.doi.org/10.1128/MCB.02279-06
55. B.P.Carson, J.M.Del Bas, J.M.Moreno-Navarrete, J.M.Fernandez-Real, S.Mora. The rab11 effector protein FIP1 regulates adiponectin trafficking and secretion. PLoS One 2013; 8:e74687; PMID:24040321; http://dx.doi.org/10.1371/journal.pone.0074687
56. S.Karki, P.Chakrabarti, G.Huang, H.Wang, S.R.Farmer, K.V.Kandror. The multi-level action of fatty acids on adiponectin production by fat cells. PLoS One 2011; 6:e28146; PMID:22140527; http://dx.doi.org/10.1371/journal.pone.0028146
57. S.Gesta, K.Lolmede, D.Daviaud, M.Berlan, A.Bouloumie, M.Lafontan, P.Valet, J.S.Saulnier-Blache. Culture of human adipose tissue explants leads to profound alteration of adipocyte gene expression. Horm Metab Res 2003; 35:158-63; PMID:12734776; http://dx.doi.org/10.1055/s-2003-39070
58. K.N.Frayn, S.W.Coppack. Assessment of white adipose tissue metabolism by measurement of arteriovenous differences. Methods Mol Biol 2001; 155:269-79; PMID:11293078
59. C.N.Bennett, H.Ouyang, Y.L.Ma, Q.Zeng, I.Gerin, K.M.Sousa, T.F.Lane, V.Krishnan, K.D.Hankenson, O.A.MacDougald. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J Bone Miner Res 2007; 22:1924-32; PMID:17708715; http://dx.doi.org/10.1359/jbmr.070810
60. W.P.Cawthorn, A.J.Bree, Y.Yao, B.Du, N.Hemati, G.Martinez-Santibanez, O.A.MacDougald. Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a beta-catenin-dependent mechanism. Bone 2012; 50:477-89; PMID:21872687; http://dx.doi.org/10.1016/j.bone.2011.08.010
61. W.P.Cawthorn, E.L.Scheller, S.D.Parlee, H.A.Pham, B.S.Learman, C.M.Redshaw, R.J.Sulston, A.A.Burr, A.K.Das, B.R.Simon, et al. Expansion of bone marrow adipose tissue during caloric restriction is associated with increased circulating glucocorticoids and not with hypoleptinemia. Endocrinology 2015:en20151477
62. A.Garg, A.K.Agarwal. Lipodystrophies:disorders of adipose tissue biology. Biochim Biophys Acta 2009; 1791:507-13; PMID:19162222; http://dx.doi.org/10.1016/j.bbalip.2008.12.014
63. A.Rajab, V.Straub, L.J.McCann, D.Seelow, R.Varon, R.Barresi, A.Schulze, B.Lucke, S.Lutzkendorf, M.Karbasiyan, et al. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS genetics 2010; 6:e1000874; PMID:20300641; http://dx.doi.org/10.1371/journal.pgen.1000874
64. C.Colombo, J.J.Cutson, T.Yamauchi, C.Vinson, T.Kadowaki, O.Gavrilova, M.L.Reitman. Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy. Diabetes 2002; 51:2727-33; PMID:12196465; http://dx.doi.org/10.2337/diabetes.51.9.2727
65. Q.A.Wang, C.Tao, R.K.Gupta, P.E.Scherer. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med 2013; 19:1338-44; PMID:23995282; http://dx.doi.org/10.1038/nm.3324
66. R.K.Semple, M.A.Soos, J.Luan, C.S.Mitchell, J.C.Wilson, M.Gurnell, E.K.Cochran, P.Gorden, V.K.Chatterjee, N.J.Wareham, et al. Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab 2006; 91:3219-23; PMID:16705075; http://dx.doi.org/10.1210/jc.2006-0166
67. R.K.Semple, N.H.Halberg, K.Burling, M.A.Soos, T.Schraw, J.Luan, E.K.Cochran, D.B.Dunger, N.J.Wareham, P.E.Scherer, et al. Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 2007; 56:1712-7; PMID:17325257; http://dx.doi.org/10.2337/db06-1665
68. M.Bluher, M.D.Michael, O.D.Peroni, K.Ueki, N.Carter, B.B.Kahn, C.R.Kahn. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 2002; 3:25-38; PMID:12110165; http://dx.doi.org/10.1016/S1534-5807(02)00199-5
69. T.Isobe, S.Saitoh, S.Takagi, H.Takeuchi, Y.Chiba, N.Katoh, K.Shimamoto. Influence of gender, age and renal function on plasma adiponectin level:the Tanno and Sobetsu study. Eur J Endocrinol 2005; 153:91-8; PMID:15994750; http://dx.doi.org/10.1530/eje.1.01930
70. A.Imagawa, T.Funahashi, T.Nakamura, M.Moriwaki, S.Tanaka, H.Nishizawa, K.Sayama, S.Uno, H.Iwahashi, K.Yamagata, et al. Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002; 25:1665-6; PMID:12196453; http://dx.doi.org/10.2337/diacare.25.9.1665
71. A.H.Berg, T.P.Combs, X.Du, M.Brownlee, P.E.Scherer. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7:947-53; PMID:11479628; http://dx.doi.org/10.1038/90992
72. A.Kharitonenkov, V.J.Wroblewski, A.Koester, Y.F.Chen, C.K.Clutinger, X.T.Tigno, B.C.Hansen, A.B.Shanafelt, G.J.Etgen. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 2007; 148:774-81; PMID:17068132; http://dx.doi.org/10.1210/en.2006-1168
73. W.Wei, P.A.Dutchak, X.Wang, X.Ding, X.Wang, A.L.Bookout, R.Goetz, M.Mohammadi, R.D.Gerard, P.C.Dechow, et al. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma. Proc Natl Acad Sci U S A 2012; 109:3143-8; PMID:22315431; http://dx.doi.org/10.1073/pnas.1200797109
74. M.Langeveld, S.Scheij, P.Dubbelhuis, C.E.Hollak, H.P.Sauerwein, P.Simons, J.M.Aerts. Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia. Metabolism 2007; 56:314-9; PMID:17292718; http://dx.doi.org/10.1016/j.metabol.2006.10.014
75. M.Maas, C.E.Hollak, E.M.Akkerman, J.M.Aerts, J.Stoker, G.J.Den Heeten. Quantification of skeletal involvement in adults with type I Gaucher's disease:fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter. AJR Am J Roentgenol 2002; 179:961-5; PMID:12239046; http://dx.doi.org/10.2214/ajr.179.4.1790961
76. D.I.Rosenthal, W.Mayo-Smith, M.M.Goodsitt, S.Doppelt, H.J.Mankin. Bone and bone marrow changes in Gaucher disease:evaluation with quantitative CT. Radiology 1989; 170:143-6; PMID:2909087; http://dx.doi.org/10.1148/radiology.170.1.2909087
77. E.B.Geer, W.Shen, E.Strohmayer, K.D.Post, P.U.Freda. Body composition and cardiovascular risk markers after remission of Cushing's disease:a prospective study using whole-body MRI. J Clin Endocrinol Metab 2012; 97:1702-11; PMID:22419708; http://dx.doi.org/10.1210/jc.2011-3123
78. C.M.Schnitzler, J.Mesquita. Bone marrow composition and bone microarchitecture and turnover in blacks and whites. J Bone Miner Res 1998; 13:1300-7; PMID:9718199; http://dx.doi.org/10.1359/jbmr.1998.13.8.1300
79. M.W.Hulver, O.Saleh, K.G.MacDonald, W.J.Pories, H.A.Barakat. Ethnic differences in adiponectin levels. Metabolism 2004; 53:1-3; PMID:14681833; http://dx.doi.org/10.1016/j.metabol.2003.07.002
80. A.L.Newton, L.J.Hanks, M.Davis, K.Casazza. The relationships among total body fat, bone mineral content and bone marrow adipose tissue in early-pubertal girls. BoneKEy Rep 2013; 2
81. E.L.Scheller, C.J.Rosen. What's the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health. Ann N Y Acad Sci 2014; 1311:14-30; PMID:24650218; http://dx.doi.org/10.1111/nyas.12327
82. J.George, S.Patal, D.Wexler, Y.Sharabi, E.Peleg, Y.Kamari, E.Grossman, D.Sheps, G.Keren, A.Roth. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 2006; 92:1420-4; PMID:16621874; http://dx.doi.org/10.1136/hrt.2005.083345
83. C.Mantzoros, E.Petridou, D.M.Alexe, A.Skalkidou, N.Dessypris, E.Papathoma, H.Salvanos, G.Shetty, A.Gavrila, S.Kedikoglou, et al. Serum adiponectin concentrations in relation to maternal and perinatal characteristics in newborns. Eur J Endocrinol 2004; 151:741-6; PMID:15588241; http://dx.doi.org/10.1530/eje.0.1510741
84. M.Styner, W.R.Thompson, K.Galior, G.Uzer, X.Wu, S.Kadari, N.Case, Z.Xie, B.Sen, A.Romaine, et al. Bone marrow fat accumulation accelerated by high fat diet is suppressed by exercise. Bone 2014; 64:39-46; PMID:24709686; http://dx.doi.org/10.1016/j.bone.2014.03.044
85. C.R.Doucette, M.C.Horowitz, R.Berry, O.A.MacDougald, R.Anunciado-Koza, R.A.Koza, C.J.Rosen. A High Fat Diet Increases Bone Marrow Adipose Tissue (MAT) But Does Not Alter Trabecular or Cortical Bone Mass in C57BL/6J Mice. J Cell Physiol 2015; 230:2032-7; PMID:25663195; http://dx.doi.org/10.1002/jcp.24954
86. B.Lecka-Czernik, L.A.Stechschulte, P.J.Czernik, A.R.Dowling. High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity. Mol Cell Endocrinol 2015; 410:35-41; PMID:25576855; http://dx.doi.org/10.1016/j.mce.2015.01.001
87. T.Baum, S.P.Yap, D.C.Karampinos, L.Nardo, D.Kuo, A.J.Burghardt, U.B.Masharani, A.V.Schwartz, X.Li, T.M.Link. Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus? J Magnetic Resonance Imaging:JMRI 2012; 35:117-24; PMID:22190287; http://dx.doi.org/10.1002/jmri.22757
88. M.A.Bredella, C.M.Gill, A.V.Gerweck, M.G.Landa, V.Kumar, S.M.Daley, M.Torriani, K.K.Miller. Ectopic and serum lipid levels are positively associated with Bone Marrow fat in obesity. Radiology 2013; PMID:23861502
89. A.L.Schafer, X.Li, A.V.Schwartz, L.S.Tufts, A.L.Wheeler, C.Grunfeld, L.Stewart, S.J.Rogers, J.T.Carter, A.M.Posselt, et al. Changes in vertebral bone marrow fat and bone mass after gastric bypass surgery:A pilot study. Bone 2015; 74:140-5; PMID:25603463; http://dx.doi.org/10.1016/j.bone.2015.01.010
90. G.V.Halade, A.El Jamali, P.J.Williams, R.J.Fajardo, G.Fernandes. Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. Exp Gerontol 2011; 46:43-52; PMID:20923699; http://dx.doi.org/10.1016/j.exger.2010.09.014
91. G.Mangialardi, G.Spinetti, C.Reni, P.Madeddu. Reactive oxygen species adversely impacts bone marrow microenvironment in diabetes. Antioxidants Redox Signaling 2014; 21:1620-33; PMID:25089632; http://dx.doi.org/10.1089/ars.2014.5944
92. K.A.Gallagher, A.Joshi, W.F.Carson, M.Schaller, R.Allen, S.Mukerjee, N.Kittan, E.L.Feldman, P.K.Henke, C.Hogaboam, et al. Epigenetic changes in bone marrow progenitor cells influence the inflammatory phenotype and alter wound healing in type 2 diabetes. Diabetes 2015; 64:1420-30; PMID:25368099; http://dx.doi.org/10.2337/db14-0872
93. J.B.Richards, D.Waterworth, S.O'Rahilly, M.F.Hivert, R.J.Loos, J.R.Perry, T.Tanaka, N.J.Timpson, R.K.Semple, N.Soranzo, et al. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet 2009; 5:e1000768; PMID:20011104; http://dx.doi.org/10.1371/journal.pgen.1000768
94. S.H.Jee, J.W.Sull, J.E.Lee, C.Shin, J.Park, H.Kimm, E.Y.Cho, E.S.Shin, J.E.Yun, J.W.Park, et al. Adiponectin concentrations:a genome-wide association study. Am J Hum Genet 2010; 87:545-52; PMID:20887962; http://dx.doi.org/10.1016/j.ajhg.2010.09.004
95. Z.Dastani, M.F.Hivert, N.Timpson, J.R.Perry, X.Yuan, R.A.Scott, P.Henneman, I.M.Heid, J.R.Kizer, L.P.Lyytikainen, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits:a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012; 8:e1002607; PMID:22479202; http://dx.doi.org/10.1371/journal.pgen.1002607
96. A.M.Cypess, S.Lehman, G.Williams, I.Tal, D.Rodman, A.B.Goldfine, F.C.Kuo, E.L.Palmer, Y.H.Tseng, A.Doria, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009; 360:1509-17; PMID:19357406; http://dx.doi.org/10.1056/NEJMoa0810780
97. N.Pannacciulli, R.Vettor, G.Milan, M.Granzotto, A.Catucci, G.Federspil, P.De Giacomo, R.Giorgino, G.De Pergola. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 2003; 88:1748-52; PMID:12679468; http://dx.doi.org/10.1210/jc.2002-021215
98. J.Housova, K.Anderlova, J.Krizova, D.Haluzikova, J.Kremen, T.Kumstyrova, H.Papezova, M.Haluzik. Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2005; 90:1366-70; PMID:15598689; http://dx.doi.org/10.1210/jc.2004-1364
99. A.Bosy-Westphal, G.Brabant, V.Haas, S.Onur, T.Paul, D.Nutzinger, H.Klein, M.Hauer, M.J.Muller. Determinants of plasma adiponectin levels in patients with anorexia nervosa examined before and after weight gain. Eur J Nutr 2005; 44:355-9; PMID:15793670; http://dx.doi.org/10.1007/s00394-005-0533-3
100. D.Modan-Moses, D.Stein, C.Pariente, A.Yaroslavsky, A.Ram, M.Faigin, R.Loewenthal, E.Yissachar, R.Hemi, H.Kanety. Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. J Clin Endocrinol Metab 2007; 92:1843-7; PMID:17327386; http://dx.doi.org/10.1210/jc.2006-1683
101. I.Dostalova, P.Kavalkova, D.Haluzikova, Z.Lacinova, M.Mraz, H.Papezova, M.Haluzik. Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J Clin Endocrinol Metab 2008; 93:3627-32; PMID:18559909; http://dx.doi.org/10.1210/jc.2008-0746
102. M.Karczewska-Kupczewska, M.Straczkowski, A.Adamska, A.Nikolajuk, E.Otziomek, M.Gorska, I.Kowalska. Insulin sensitivity, metabolic flexibility, and serum adiponectin concentration in women with anorexia nervosa. Metabolism 2010; 59:473-7; PMID:19846178; http://dx.doi.org/10.1016/j.metabol.2009.07.036
103. X.Terra, T.Auguet, Z.Aguera, I.M.Quesada, J.M.Orellana-Gavalda, C.Aguilar, S.Jimenez-Murcia, A.Berlanga, E.Guiu-Jurado, J.M.Menchon, et al. Adipocytokine levels in women with anorexia nervosa. Relationship with weight restoration and disease duration. Int J Eat Disord 2013; 46:855-61; PMID:23881663; http://dx.doi.org/10.1002/eat.22166
104. M.Misra, K.K.Miller, C.Almazan, K.Ramaswamy, A.Aggarwal, D.B.Herzog, G.Neubauer, J.Breu, A.Klibanski. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab 2004; 89:3486-95; PMID:15240636; http://dx.doi.org/10.1210/jc.2003-032251
105. J.P.Nogueira, M.Maraninchi, A.M.Lorec, A.B.Corroller, A.Nicolay, J.Gaudart, H.Portugal, R.Barone, B.Vialettes, R.Valero. Specific adipocytokines profiles in patients with hyperactive and/or binge/purge form of anorexia nervosa. Eur J Clin Nutr 2010; 64:840-4; http://dx.doi.org/10.1038/ejcn.2010.66
106. H.Amitani, A.Asakawa, K.Ogiso, T.Nakahara, M.Ushikai, I.Haruta, K.Koyama, M.Amitani, K.C.Cheng, A.Inui. The role of adiponectin multimers in anorexia nervosa. Nutrition 2013; 29:203-6; PMID:23237649; http://dx.doi.org/10.1016/j.nut.2012.07.011
107. T.Tagami, N.Satoh, T.Usui, K.Yamada, A.Shimatsu, H.Kuzuya. Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2004; 89:1833-7; PMID:15070952; http://dx.doi.org/10.1210/jc.2003-031260
108. H.Iwahashi, T.Funahashi, N.Kurokawa, K.Sayama, E.Fukuda, K.Okita, A.Imagawa, K.Yamagata, I.Shimomura, J.I.Miyagawa, et al. Plasma adiponectin levels in women with anorexia nervosa. Horm Metab Res 2003; 35:537-40; PMID:14517770; http://dx.doi.org/10.1055/s-2003-42655
109. M.A.Bredella, P.K.Fazeli, S.M.Daley, K.K.Miller, C.J.Rosen, A.Klibanski, M.Torriani. Marrow fat composition in anorexia nervosa. Bone 2014
110. P.K.Fazeli, M.A.Bredella, L.Freedman, B.J.Thomas, A.Breggia, E.Meenaghan, C.J.Rosen, A.Klibanski. Marrow fat and preadipocyte factor-1 levels decrease with recovery in women with anorexia nervosa. J Bone Miner Res 2012; PMID:22508185
111. P.K.Fazeli, M.A.Bredella, M.Misra, E.Meenaghan, C.J.Rosen, D.R.Clemmons, A.Breggia, K.K.Miller, A.Klibanski. Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. J Clin Endocrinol Metab 2010; 95:407-13; PMID:19850693; http://dx.doi.org/10.1210/jc.2009-1152
112. K.Ecklund, S.Vajapeyam, H.A.Feldman, C.D.Buzney, R.V.Mulkern, P.K.Kleinman, C.J.Rosen, C.M.Gordon. Bone marrow changes in adolescent girls with anorexia nervosa. J Bone Miner Res 2010; 25:298-304; PMID:19653811; http://dx.doi.org/10.1359/jbmr.090805
113. M.A.Bredella, P.K.Fazeli, K.K.Miller, M.Misra, M.Torriani, B.J.Thomas, R.H.Ghomi, C.J.Rosen, A.Klibanski. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab 2009; 94:2129-36; PMID:19318450; http://dx.doi.org/10.1210/jc.2008-2532
114. K.Shinmura, K.Tamaki, K.Saito, Y.Nakano, T.Tobe, R.Bolli. Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase. Circulation 2007; 116:2809-17; PMID:18040027; http://dx.doi.org/10.1161/CIRCULATIONAHA.107.725697
115. Z.Wang, M.M.Masternak, K.A.Al-Regaiey, A.Bartke. Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology 2007; 148:2845-53; PMID:17347312; http://dx.doi.org/10.1210/en.2006-1313
116. J.I.Fenton, N.P.Nunez, S.Yakar, S.N.Perkins, N.G.Hord, S.D.Hursting. Diet-induced adiposity alters the serum profile of inflammation in C57BL/6N mice as measured by antibody array. Diabetes, obesity & metabolism 2009; 11:343-54; http://dx.doi.org/10.1111/j.1463-1326.2008.00974.x
117. K.A.Varady, C.A.Allister, D.J.Roohk, M.K.Hellerstein. Improvements in body fat distribution and circulating adiponectin by alternate-day fasting versus calorie restriction. J Nutr Biochem 2010; 21:188-95; PMID:19195863; http://dx.doi.org/10.1016/j.jnutbio.2008.11.001
118. A.E.Harvey, L.M.Lashinger, G.Otto, N.P.Nunez, S.D.Hursting. Decreased systemic IGF-1 in response to calorie restriction modulates murine tumor cell growth, nuclear factor-kappaB activation, and inflammation-related gene expression. Mol Carcinog 2013; 52:997-1006; PMID:22778026; http://dx.doi.org/10.1002/mc.21940
119. M.Zhu, J.Miura, L.X.Lu, M.Bernier, R.DeCabo, M.A.Lane, G.S.Roth, D.K.Ingram. Circulating adiponectin levels increase in rats on caloric restriction:the potential for insulin sensitization. Exp Gerontol 2004; 39:1049-59; PMID:15236764; http://dx.doi.org/10.1016/j.exger.2004.03.024
120. N.Sharma, C.M.Castorena, G.D.Cartee. Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines. Nutr Metab (Lond) 2012; 9:90; PMID:23067400; http://dx.doi.org/10.1186/1743-7075-9-90
121. K.A.Varady, D.J.Roohk, Y.C.Loe, B.K.McEvoy-Hein, M.K.Hellerstein. Effects of modified alternate-day fasting regimens on adipocyte size, triglyceride metabolism, and plasma adiponectin levels in mice. J Lipid Res 2007; 48:2212-9; PMID:17607017; http://dx.doi.org/10.1194/jlr.M700223-JLR200
122. L.Piccio, J.L.Stark, A.H.Cross. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J Leukoc Biol 2008; 84:940-8; PMID:18678605; http://dx.doi.org/10.1189/jlb.0208133
123. H.Y.Jiang, T.Koike, P.Li, Z.H.Wang, Y.Kawata, Y.Oshida. Combined effects of short-term calorie restriction and exercise on insulin action in normal rats. Horm Metab Res 2010; 42:950-4; PMID:20938891; http://dx.doi.org/10.1055/s-0030-1267174
124. L.Fontana, S.Klein, J.O.Holloszy. Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production. Age 2010; 32:97-108; PMID:19904628; http://dx.doi.org/10.1007/s11357-009-9118-z
125. D.T.Villareal, L.Fontana, S.K.Das, L.Redman, S.R.Smith, E.Saltzman, C.Bales, J.Rochon, C.Pieper, M.Huang, et al. Effect of two-year caloric restriction on Bone metabolism and Bone mineral density in non-obese younger adults:a randomized clinical trial. J Bone Miner Res 2015; [Epub ahead of print]; PMID:26332798; http://dx.doi.org/10.1002/jbmr.2701
126. E.P.Weiss, S.B.Racette, D.T.Villareal, L.Fontana, K.Steger-May, K.B.Schechtman, S.Klein, J.O.Holloszy. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake:a randomized controlled trial. Am J Clin Nutr 2006; 84:1033-42; PMID:17093155
127. B.E.Wolfe, D.C.Jimerson, C.Orlova, C.S.Mantzoros. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol (Oxf) 2004; 61:332-8; PMID:15355449; http://dx.doi.org/10.1111/j.1365-2265.2004.02101.x
128. J.Karschin, M.Lagerpusch, J.Enderle, B.Eggeling, M.J.Muller, A.Bosy-Westphal. Endocrine determinants of changes in insulin sensitivity and insulin secretion during a weight cycle in healthy men. PLoS One 2015; 10:e0117865; PMID:25723719; http://dx.doi.org/10.1371/journal.pone.0117865
129. W.A.Haque, I.Shimomura, Y.Matsuzawa, A.Garg. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 2002; 87:2395; PMID:11994394; http://dx.doi.org/10.1210/jcem.87.5.8624
130. B.Antuna-Puente, E.Boutet, C.Vigouroux, O.Lascols, L.Slama, M.Caron-Debarle, E.Khallouf, C.Levy-Marchal, J.Capeau, J.P.Bastard, et al. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency. J Clin Endocrinol Metab 2010; 95:1463-8; PMID:20097706; http://dx.doi.org/10.1210/jc.2009-1824
131. S.Shastry, M.R.Delgado, E.Dirik, M.Turkmen, A.K.Agarwal, A.Garg. Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. Am J Med Genet Part A 2010; 152A:2245-53; PMID:20684003; http://dx.doi.org/10.1002/ajmg.a.33578
132. E.K.Dwianingsih, Y.Takeshima, K.Itoh, Y.Yamauchi, H.Awano, R.G.Malueka, A.Nishida, M.Ota, M.Yagi, M.Matsuo. A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4. Mol Genet Metab 2010; 101:233-7; PMID:20638880; http://dx.doi.org/10.1016/j.ymgme.2010.06.016
133. C.A.Kim, M.Delepine, E.Boutet, H.El Mourabit, S.Le Lay, M.Meier, M.Nemani, E.Bridel, C.C.Leite, D.R.Bertola, et al. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab 2008; 93:1129-34; PMID:18211975; http://dx.doi.org/10.1210/jc.2007-1328
134. A.Garg, R.M.Peshock, J.L.Fleckenstein. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab 1999; 84:170-4; PMID:9920078
135. J.S.Huang, R.V.Mulkern, S.Grinspoon. Reduced intravertebral bone marrow fat in HIV-infected men. AIDS 2002; 16:1265-9; PMID:12045492; http://dx.doi.org/10.1097/00002030-200206140-00009
136. A.Misra, A.Garg. Clinical features and metabolic derangements in acquired generalized lipodystrophy:case reports and review of the literature. Medicine (Baltimore) 2003; 82:129-46; PMID:12640189; http://dx.doi.org/10.1097/00005792-200303000-00007
137. P.Koutkia, S.Grinspoon. HIV-associated lipodystrophy:pathogenesis, prognosis, treatment, and controversies. Annu Rev Med 2004; 55:303-17; PMID:14746523; http://dx.doi.org/10.1146/annurev.med.55.091902.104412
138. P.B.Mory, F.Crispim, M.B.Freire, J.E.Salles, C.M.Valerio, A.F.Godoy-Matos, S.A.Dib, R.S.Moises. Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations. Eur J Endocrinol 2012; 167:423-31; PMID:22700598; http://dx.doi.org/10.1530/EJE-12-0268